Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania.
Department of Surgery, University of Virginia, Charlottesville, Virginia.
J Surg Res. 2023 Sep;289:35-41. doi: 10.1016/j.jss.2023.03.019. Epub 2023 Apr 18.
The robotic platform reduces the invasiveness of cardiac surgical procedures, thus facilitating earlier discharge in select patients. We sought to evaluate the characteristics, perioperative management, and early outcomes of patients who underwent postoperative day 1 or 2 (POD1-2) discharge after robotic cardiac surgery at our institution.
Retrospective review of 169 patients who underwent robotic cardiac surgery at our facility between 2019 and 2021 identified 57 patients discharged early on POD1 (n = 19) or POD2 (n = 38) and 112 patients who underwent standard discharge (POD3 or later). Relevant data were extracted and compared.
In the early discharge group, median patient age was 62 [IQR: 55, 66] (IQR = interquartile range) years, and 70.2% (40/57) were male. Median Society of Thoracic Surgeons predictive risk of mortality score was 0.36 [IQR: 0.25, 0.56] %. The most common procedures performed were mitral valve repair [66.6%, (38/57)], atrial mass resection [10.5% (6/57)], and coronary artery bypass grafting [10.5% (6/57)]. The only significant differences between the POD1 and POD2 groups were shorter operative time, higher rate of in-operating room extubation, and shorter ICU length of stay in the POD1 group. Lower in-hospital morbidity and comparable 30-day mortality and readmission rates were observed between the early and standard discharge groups.
POD1-2 discharge after various robotic cardiac operations afforded lower morbidity and similar 30-day readmission and mortality rates compared to discharge on POD3 or later. Our findings support the feasibility of POD1-2 discharge after robotic cardiac surgery for patients with low preoperative risk, an uncomplicated postoperative course, and appropriate postoperative management protocols.
机器人平台降低了心脏外科手术的侵袭性,从而使部分患者能够更早出院。我们旨在评估我院行机器人心脏手术后第 1 天或第 2 天(POD1-2)出院患者的特征、围手术期管理和早期结局。
回顾性分析了 2019 年至 2021 年在我院行机器人心脏手术的 169 例患者,其中 57 例患者早期出院(POD1:19 例,POD2:38 例),112 例患者标准出院(POD3 及以后)。提取并比较了相关数据。
在早期出院组中,患者中位年龄为 62 [IQR:55,66] 岁,70.2%(40/57)为男性。中位胸外科医师学会预测死亡率评分 0.36 [IQR:0.25,0.56]%。最常见的手术方式为二尖瓣修复术[66.6%(38/57)]、心房肿块切除术[10.5%(6/57)]和冠状动脉旁路移植术[10.5%(6/57)]。POD1 组与 POD2 组唯一的显著差异是手术时间更短、手术室拔管率更高以及 ICU 住院时间更短。早期出院组和标准出院组的院内发病率较低,30 天死亡率和再入院率相当。
与 POD3 或以后出院相比,各种机器人心脏手术后第 1 天至第 2 天出院可降低发病率,且 30 天再入院率和死亡率相当。我们的研究结果支持对于术前风险低、术后过程简单、以及术后管理方案适当的患者,行机器人心脏手术后第 1 天至第 2 天出院是可行的。